Evidence map›Paper›PMID 36676104›Full record

ArticleLife (Basel, Switzerland)2023

A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma.

Iker Malaina, Luis Martínez, Juan Manuel Montoya, Santos Alonso, María Dolores Boyano, Aintzane Asumendi, Rosa Izu, Ana Sanchez-Diez, Goikoane Cancho-Galan, Ildefonso M de la Fuente

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Iker MalainaDepartment of Mathematics, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0002-1305-6623
Luis MartínezDepartment of Mathematics, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0002-6297-1449
Juan Manuel MontoyaDepartment of Mathematics, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.
Santos AlonsoDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0003-0221-4048
María Dolores BoyanoDepartment of Cell Biology and Histology, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0001-6051-1054
Aintzane AsumendiDepartment of Cell Biology and Histology, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0002-2156-2323
Rosa IzuBiocruces Bizkaia Health Research Institute, 48903 Bizkaia, Spain.
Ana Sanchez-DiezBiocruces Bizkaia Health Research Institute, 48903 Bizkaia, Spain.
Goikoane Cancho-GalanBiocruces Bizkaia Health Research Institute, 48903 Bizkaia, Spain.
Ildefonso M de la FuenteDepartment of Mathematics, University of the Basque Country UPV/EHU, 48940 Bizkaia, Spain.ORCID 0000-0001-6548-7583
University of the Basque Country · ESBioCruces Health research Institute · ES

Funding

Basque Government IT456-22University of the Basque Country US21/27
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformaticscombinatorial optimizationimmunogenicitymelanomapersonalized medicinevaccine design

Identifiers

PMID36676104
PMCPMC9867041
OpenAlexW4313574519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.